NSC |
Compound |
Enrichment |
Correlation |
NSC 698980 |
Null |
0.0176693828663438 |
-0.056037783 |
NSC 723397 |
Null |
0.0176693828663438 |
0.26755656 |
NSC 726195 |
2-phenyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one |
0.0176693828663438 |
0.25451532 |
NSC 744622 |
4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide |
0.0176693828663438 |
0.19854318 |
NSC 750717 |
5-(2-hydroxyethyl)-9-(3-methoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-8(5H)-one |
0.0176693828663438 |
0.29450522 |
NSC 764043 |
(+)-JQ1 |
0.0176693828663438 |
0.12445897 |
NSC 269599 |
Stannane, chlorohydroxydiphenyl- |
0.0181211508101517 |
0.29330427 |
NSC 363812 |
Tetraplatin |
0.0181211508101517 |
0.46719443 |
NSC 36437 |
14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) |
0.0181211508101517 |
0.40409095 |
NSC 39135 |
Null |
0.0181211508101517 |
0.49706326 |